NAT-TERIFLUNOMIDE

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: a363611fc0266a8f
Drug Approval Canada Name: NAT-TERIFLUNOMIDE
Product Name: NAT-TERIFLUNOMIDE
Status: Marketed
Status Date: 2022-05-16
Original Market Date: 2022-05-16
Din: 02500310
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 90:04.20
Atc Original: L04AK02 TERIFLUNOMIDE
Atc Name: l 04 ak 02
Aig Number: 0154970001
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

TERIFLUNOMIDE

14 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a363611fc0266a8f

Type

Standard